Department of Internal Medicine, University of Miami/Jackson Memorial Hospital, Miami, Florida.
Department of Internal Medicine, University of Miami/Jackson Memorial Hospital, Miami, Florida.
Heart Rhythm. 2021 Jun;18(6):987-994. doi: 10.1016/j.hrthm.2021.02.008. Epub 2021 Feb 12.
Select patients with atrial fibrillation and contraindication to anticoagulation may benefit from percutaneous left atrial appendage closure (pLAAC).
The purpose of this study was to evaluate racial disparities in the nationwide utilization and outcomes of pLAAC.
We identified 16,830 hospitalizations for pLAAC between 2015 and 2017 using the National Inpatient Sample. Baseline characteristics, in-hospital mortality, complications, length of stay, and discharge disposition were assessed between White and Black/African American (AA) populations.
Black/AA patients represented 4.1% of nationwide pLAAC recipients and were younger, more likely to be female, and had greater prevalence of hypertension, heart failure, hyperlipidemia, obesity, chronic kidney disease, and prior stroke history (P <.001 for all). Black/AA patients had significantly increased length of stay and nonroutine discharge (P <.001 for both) but comparable in-hospital mortality to White patients. Black/AA patients suffered from greater postoperative stroke (0.7% vs 0.2%), acute kidney injury (4.5% vs 2.1%), bleeding requiring transfusion (4.5% vs 1.4%), and venous thromboembolism (0.7% vs 0.1%; P <.01 for all). After controlling for possible confounding factors, Black/AA race was independently associated with significantly increased odds of bleeding requiring blood transfusion, stroke, venous thromboembolism, and nonroutine discharge.
Among pLAAC recipients nationwide, Black/AA populations were underrepresented and had greater complication rates, length of stay, and discharge complexity. This study highlights the importance of addressing ongoing racial disparities in both utilization and outcomes of pLAAC.
对于有房颤且有抗凝禁忌的患者,经皮左心耳封堵术(pLAAC)可能有益。
本研究旨在评估全国范围内 pLAAC 的利用情况和结局的种族差异。
我们使用国家住院患者样本(National Inpatient Sample),于 2015 年至 2017 年期间确定了 16830 例 pLAAC 住院患者。评估白人和黑种人/非裔美国人(AA)人群之间的基线特征、住院死亡率、并发症、住院时间和出院去向。
黑种人/非裔美国人患者占全国 pLAAC 接受者的 4.1%,他们更年轻,更可能为女性,且高血压、心力衰竭、高脂血症、肥胖、慢性肾脏病和既往中风史的患病率更高(所有 P<.001)。黑种人/非裔美国人患者的住院时间和非常规出院比例明显更高(两者均 P<.001),但与白人患者的院内死亡率相当。黑种人/非裔美国人患者术后中风(0.7%比 0.2%)、急性肾损伤(4.5%比 2.1%)、需要输血的出血(4.5%比 1.4%)和静脉血栓栓塞(0.7%比 0.1%;所有 P<.01)的发生率更高。在控制可能的混杂因素后,黑种人/非裔美国人种族与需要输血的出血、中风、静脉血栓栓塞和非常规出院的几率显著增加独立相关。
在全国范围内接受 pLAAC 的患者中,黑种人/非裔美国人人群代表性不足,且并发症发生率、住院时间和出院复杂性更高。本研究强调了在 pLAAC 的利用情况和结局方面解决持续存在的种族差异的重要性。